Stay updated on Efficacy of Nivolumab and Ipilimumab in Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Efficacy of Nivolumab and Ipilimumab in Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy of Nivolumab and Ipilimumab in Esophageal Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study locations have been expanded with multiple new sites worldwide, and the follow-up periods for overall survival and progression-free survival have been extended to up to 88 months, with several previously listed sites and shorter timeframes removed.
    Difference
    2%
    Check dated 2026-02-18T16:51:43.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A new revision tag, Revision: v3.4.2, was added to the page; the previous maintenance notice about a lapse in government funding and the Revision: v3.4.1 tag were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-11T14:09:37.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a site-wide notice about potential delays due to a lapse in government funding and the NIH Clinical Center's operating status, and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-04T10:18:38.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    UI and labeling updates include a glossary toggle and capitalization changes to QC-related text and revision/version notices. These changes do not affect the study content, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-01-28T04:55:44.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces v3.3.3 on the page, a minor update that does not affect study details, eligibility, or results; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:24:16.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The Locations section now lists a comprehensive set of trial sites across the United States, Argentina, Australia, Brazil, Canada, Chile, China, and other regions, replacing the previous location listing. This provides clearer visibility of where the study is conducted and helps potential participants find nearby sites.
    Difference
    3%
    Check dated 2025-12-23T20:25:35.000Z thumbnail image

Stay in the know with updates to Efficacy of Nivolumab and Ipilimumab in Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy of Nivolumab and Ipilimumab in Esophageal Cancer Clinical Trial page.